The human coronavirus NL63 (HCoV-NL63) was first identified in the Netherlands, and its circulation in France has not been investigated. We studied HCoV-NL63 infection in hospitalized children diagnosed with respiratory tract infections. From November 2002 to April 2003, we evaluated 300 respiratory specimens for HCoV-NL63. Of the 300 samples, 28 (9.3%) were positive for HCoV-NL63. The highest prevalence was found in February (18%). The main symptoms were fever (61%), rhinitis (39%), bronchiolitis (39%), digestive problems (33%), otitis (28%), pharyngitis (22%), and conjunctivitis (17%). A fragment of the spike protein gene was sequenced to determine the variety of circulating HCoV-NL63. Phylogenetic analysis indicated that strains with different genetic markers cocirculate in France.
CITATION STYLE
Vabret, A., Mourez, T., Dina, J., Van Der Hoek, L., Gouarin, S., Petitjean, J., … Freymuth, F. (2005). Human coronavirus NL63, France. Emerging Infectious Diseases, 11(8), 1225–1229. https://doi.org/10.3201/eid1108.050110
Mendeley helps you to discover research relevant for your work.